Press release
VESTAMID
May 8, 2017

Evonik at the 22nd Iran International Oil, Gas, Refining and Petrochemicals Exhibition

“Evonik has been present in Iran for forty eight years and considers the country a key growth market especially in the energy sector where it has 11% of oil and 18% of gas reserves of the world,” says Sassan Pakdel, Business Sales Manager for High Performance Polymers at Evonik Iran.

“Participating in this exhibition shows our commitment as a company to developing and supporting the Iranian energy sector through the various technologies that we offer,” Pakdel added.

While Evonik offers solutions that address different needs in the three energy markets of upstream, midstream and downstream including corrosion inhibitors, additives for drilling and gas processing chemistries, the company highlights at the show one key solution used for gas pipes, liners and steel pipes called VESTAMID® NRG polyamide 12 (PA 12).

VESTAMID® NRG offers outstanding properties suitable for high-pressure gas pipelines that enables gas utilities to effectively build-up their subterranean pipeline networks without any concern about losses in throughput performance.

The product line also combines the established liner technology and the custom-tailored products from Evonik that can be an alternative to corrosion resistant alloy pipes. Unlike corrosion resistant alloy pipes currently used for hydrocarbon transportation and carbon steel pipes, VESTAMID® NRG protects against internal corrosion and offers an enormous weight and price advantage.

Visit our booth this week at Iran International Oil, Gas, Refining and Petrochemicals Exhibition in hall 35 number 35.1878 or ask Sassan Pakdel for more information: sassan.pakdel@evonik.com, +98 912 959 1769 .

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world with more than 35,000 employees. In fiscal 2016 the enterprise generated sales of around €12,7 billion and an operating profit (adjusted EBITDA) of about €2.165 Billion.